Home › Spinal Cord Injuries › NCT06000592
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
Safety, Feasibility, and Efficacy of Transcutaneous Spinal Cord Stimulation on Stabilizing Blood Pressure for Acute Inpatients With Spinal Cord Injury
Who can join
Ages 14 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Newly injured patients with traumatic SCI * Admitted to Acute Inpatient Rehabilitation at Mount Sinai * Within one year of SCI * Seated hypotension (systolic BP ≤ 110 mmHg for males or ≤ 100 mmHg for females) * Orthostatic hypotension (fall in systolic BP ≥ 20 mmHg and/or a fall in diastolic BP ≥ 10 mmHg within 10 minutes of assuming an upright position) * Daily fluctuation in systolic BP ≥ 20 mmHg and/or fluctuation in diastolic BP ≥ 10 mmHg * At least 14 years old Exclusion Criteria: * Implanted brain/spine/nerve stimulators * Cochlear implants * Cardiac pacemaker/defibrillator, or intracardiac lines * Open skin lesions on or near the electrode placement sites (neck, upper back) * Significant coronary artery or cardiac conduction disease * Recent history of myocardial infarction * Insufficient mental capacity to understand and independently provide consent * Pregnancy * Cancer * Deemed unsuitable by study physician
About the study
Current forms of pharmacologic and non-pharmacologic treatments for hypotension and orthostatic hypotension (OH) remain inadequate during acute inpatient rehabilitation (AIR) following a traumatic spinal cord injury (SCI). A critical need exists for the identification of safe, practical, and effective treatment options that stabilize blood pressure (BP) after traumatic SCI. Recent published evidence suggests that transcutaneous Spinal Cord Stimulation (TSCS) can be used to raise seated BP, and mitigate the falls in BP during orthostatic repositioning in individuals with chronic SCI. This site-specific project will focus on the use of TSCS to stabilizing seated BP and mitigate the fall in BP during orthostatic repositioning during AIR following traumatic SCI.
What is being tested
- Digitimer (device)
Sponsor: Jill M. Wecht, Ed.D. · Participants: 50 · Started: Jan 1, 2022
Contact the study team
- Jorge Chavez, BS · Phone: (914)343-0713
- Jill M Wecht, EdD · Phone: (718)584-9000
Official record on ClinicalTrials.gov — NCT06000592
Locations in the U.S.
| New York | The Icahn School of Medicine at Mount Sinai, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.